TLDR NHS England will roll out Microsoft 365 Copilot to 505,000 clinicians and support staff by October 2026. A trial of 30,000+ workers across 90 NHS organizationsTLDR NHS England will roll out Microsoft 365 Copilot to 505,000 clinicians and support staff by October 2026. A trial of 30,000+ workers across 90 NHS organizations

Is Microsoft (MSFT) Stock a Buy After Landing the NHS’s Biggest AI Deal?

2026/06/08 23:11
3분 읽기
이 콘텐츠에 대한 의견이나 우려 사항이 있으시면 crypto.news@mexc.com으로 연락주시기 바랍니다

TLDR

  • NHS England will roll out Microsoft 365 Copilot to 505,000 clinicians and support staff by October 2026.
  • A trial of 30,000+ workers across 90 NHS organizations found AI saved 43 minutes per person per day.
  • The full deployment could save millions of hours of admin time annually across the NHS.
  • The rollout includes Copilot Studio, allowing NHS trusts to build custom AI agents for specific tasks.
  • MSFT stock trades around $413.25, roughly 25% below its 52-week high of $555.45.

Microsoft’s AI push in healthcare just got its biggest real-world proof point yet.


MSFT Stock Card
Microsoft Corporation, MSFT

NHS England announced on June 7 that it will deploy Microsoft 365 Copilot to 505,000 clinicians and support staff. It follows what Microsoft UK described as the largest AI trial of its kind globally in healthcare.

The trial ran across more than 30,000 workers and 90 NHS organizations. The headline finding: AI-powered admin support saved an average of 43 minutes per staff member per day — the equivalent of five weeks of time per person per year.

NHS England said a full rollout could save millions of hours annually. The deployment plan starts with 200,000 users in the first six months, with the remaining 305,000 onboarded by October 2026.

MSFT stock was trading at $413.25 at the time of writing, down 0.82% on the day. The stock has declined around 9.5% over the past week and sits about 25% below its 52-week high of $555.45.

The deal is not just a Copilot license. It includes access to Copilot Studio, which lets individual NHS trusts build and deploy their own AI agents for specific challenges — things like help desk support, complaints processing, and financial analysis.

What the AI Will Actually Do Day-to-Day

Ward clerks are expected to use it for patient discharge and bed management. Medical secretaries will use it for meeting minutes and templates. Management teams will lean on it for drafting board papers and briefings.

Core services including HR, finance, and procurement are also in scope. Agent 365 will provide governance to make sure agents comply with organizational policies.

Rob Thompson, Chief Digital, Data and Technology Officer at NHS England, said the potential to save clinical staff nearly a day’s worth of admin time every fortnight “could be a gamechanger for patients.”

The Broader Microsoft Picture

The NHS announcement lands as Microsoft continues to build out its AI platform. At its Build 2026 conference, the company outlined a shift from AI assistants to what it’s calling a full-stack enterprise agent platform.

TD Cowen and Cantor Fitzgerald both hold positive ratings on MSFT — Buy and Overweight, respectively. TD Cowen highlighted seven new self-built AI models aimed at fine-tuning and cost optimization.

Microsoft’s revenue stands at $318.3 billion with a P/E ratio of 24.71. Its market cap is $3.1 trillion.

Reid Hoffman, co-founder of LinkedIn, recently announced he will step down from Microsoft’s board to focus on his AI startup, Manas.

The NHS rollout is set to be completed by October 2026, with a 12-month onboarding plan and an extensive training program for staff.

The post Is Microsoft (MSFT) Stock a Buy After Landing the NHS’s Biggest AI Deal? appeared first on CoinCentral.

시장 기회
Gensyn 로고
Gensyn 가격(AI)
$0.02319
$0.02319$0.02319
+2.83%
USD
Gensyn (AI) 실시간 가격 차트

Predict & Trade to Win Rewards

Predict & Trade to Win RewardsPredict & Trade to Win Rewards

Guaranteed rewards with $500,000 prize pool

면책 조항: 본 사이트에 재게시된 글들은 공개 플랫폼에서 가져온 것으로 정보 제공 목적으로만 제공됩니다. 이는 반드시 MEXC의 견해를 반영하는 것은 아닙니다. 모든 권리는 원저자에게 있습니다. 제3자의 권리를 침해하는 콘텐츠가 있다고 판단될 경우, crypto.news@mexc.com으로 연락하여 삭제 요청을 해주시기 바랍니다. MEXC는 콘텐츠의 정확성, 완전성 또는 시의적절성에 대해 어떠한 보증도 하지 않으며, 제공된 정보에 기반하여 취해진 어떠한 조치에 대해서도 책임을 지지 않습니다. 본 콘텐츠는 금융, 법률 또는 기타 전문적인 조언을 구성하지 않으며, MEXC의 추천이나 보증으로 간주되어서는 안 됩니다.

RealStocks Now Live

RealStocks Now LiveRealStocks Now Live

Trade real U.S. stock via regulated brokerage